Open access
Sep 2026
Longitudinal gut microbiome dynamics during immunotherapy identify microbial features of clinical benefit in advanced primary liver cancer.
BACKGROUND The gut microbiome has been linked to immune checkpoint inhibitor (ICI) outcomes, but the temporal dynamics of microbial communities during treatment remain poorly characterised. OBJECTIVE To characterise gut microbiome trajectories during ICI therapy and evaluate whether on-treatment microbial states impr...
Zhen-Wei Qian, Jie Han, Beile Lyu et al.
· Gut · 0 citations